TARYN TEYKL: Open Payments
NPI 1518215383 · WHARTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 24 payments from 12 companies in 2025. Trend: 2023 $1,202 · 2024 $880 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $110 |
| Antares Pharma, Inc. | 5 | $109 |
| BIOTISSUE HOLDINGS INC. | 1 | $53 |
| 180 Medical, Inc. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Verity Pharmaceuticals Inc. | 2 | $42 |
| Olympus America Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| ConvaTec Inc. | 1 | $25 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
Products named: XYOSTED, BOTOX, GEMTESA, iTIND System, KEYTRUDA, Trelstar, CURE DEXTRA, LUPRON DEPOT.
Industry payments across TX — which companies pay providers there.
